Actively Recruiting

Age: 18Years +
All Genders
ID04475354

Mechanisms Explaining Psychological Distress in Cervical Cancer Patients and Partners (DICE): A Population-Based Prospective Study

Led by Comprehensive Cancer Centre The Netherlands · Updated on 2023-12-06

832

Participants Needed

6

Research Sites

313 weeks

Total Duration

On this page

Sponsors

C

Comprehensive Cancer Centre The Netherlands

Lead Sponsor

T

Tilburg University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying psychological distress in cervical cancer patients and their partners to understand why some patients experience ongoing anxiety, depression, cancer worry, and stress after diagnosis. This prospective population-based study focuses on various factors including personal, clinical, and environmental characteristics, as well as biological functions like hormone levels and inflammation. The study also aims to assess the impact of cervical cancer on partners' psychological distress and relationship quality. The study includes newly diagnosed cervical cancer patients (stage 1-3) and their partners from treatment centers in the Netherlands. Participants complete questionnaires shortly after diagnosis and at 6 months, 1, 2, 5, and 10 years. A subset of patients also provide blood and scalp hair samples and wear activity trackers to measure physical activity, sleep, and heart rate variability at diagnosis and at 6, 12, and 24 months. Participants will fill out questionnaires about psychological distress, health quality, and sexual health at multiple timepoints. Patients complete an online food diary for 3 days and provide biological samples for inflammation and hormone analysis. Physical activity and sleep are tracked using wearable devices. The study monitors anxiety and depression primarily at 24 months, with ongoing follow-up for 10 years to better understand long-term psychological outcomes and quality of life.

CONDITIONS

Brief Title

Distress In CErvical Cancer Patients and Partners

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Newly diagnosed with cervical cancer stage I, II, or III
  • 18 years of age or older
  • Partner of a patient participating in the study (for partners)
Not Eligible

You will not qualify if you...

  • Cognitive impairment preventing completion of questionnaires without assistance
  • Unable to read or write Dutch, making questionnaire completion impossible

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - Shortly after diagnosis

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote) for eligibility and initial questionnaire completion

Diagnostic Evaluation

Duration - At diagnosis

Participants complete baseline questionnaires and provide biological samples or wear monitoring devices as part of baseline assessments in a subsample.

1 baseline visit for questionnaire, online food diary, and for subsample blood and hair samples collection, and device fitting

Long-term Monitoring

Duration - Up to 10 years after diagnosis

Participants complete follow-up questionnaires at multiple timepoints and subsample participants provide repeated biological samples and wear monitoring devices.

Questionnaire completion at 6 months, 1, 2, 5, and 10 years; subsample provides blood and hair samples and wears devices at 6, 12, and 24 months

Trial Site Locations

Total: 6 locations

1

Amphia

Breda, Netherlands

Actively Recruiting

2

Catharina Hospital

Eindhoven, Netherlands

Actively Recruiting

3

University Medical Center Groningen

Groningen, Netherlands

Actively Recruiting

4

MUMC

Maastricht, Netherlands

Actively Recruiting

5

RadboudUMC

Nijmegen, Netherlands

Actively Recruiting

6

UMC Utrecht

Utrecht, Netherlands

Actively Recruiting

Loading map...

Research Team

N

Nicole Ezendam, PhD

B

Belle de Rooij, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Phase 1/2a Study of the Safety, Tolerability, and Prelimin...

Castration-Resistant Prostate Cancer (CRPC)

Actively Recruiting

4 locations

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

A Phase 1/2 Open Label, Dose Escalation and Expansion Study ...

Advanced Solid Tumor

Actively Recruiting

27 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here